Abbvie (ABBV) PT Raised to $212 at Barclays
Tweet
Share
E-mailGet Alerts ABBV Hot Sheet
Price: $249.46 -0.54%
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Barclays analyst Carter Gould raised the price target on Abbvie (NYSE: ABBV) to $212.00 (from $200.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Wolfe Research Upgrades Abbvie (ABBV) to Outperform
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Apollo Hospitals (APLH:IN) PT Raised to INR8,500 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
